Skip to main content

Animations

MJFF Publications

6081 - 6090 of 6515 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2023
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Analysis of factors associated with early stage Parkinson’s disease based on daily activities and sleeping behaviour disorder
    Journal Name: Journal of Physics: Conference Series
    Publisher: IOP Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1088/1742-6596/1722/1/012045
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Identification of risk factors for impulse-control disorder symptoms in patients with Parkinson’s disease
    Journal Name: Journal of Physics: Conference Series
    Publisher: IOP Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1088/1742-6596/1722/1/012099
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects
    Journal Name: Current Medical Research and Opinion
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1080/03007995.2021.1965975
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Classification based levodopamine response prediction in parkinson’s disorder
    Journal Name: Applied Artificial Intelligence
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/08839514.2021.1975881
    Citation Count: 1
  • Summary Details
    OPEN
    Title: K2S2O8-mediated coupling of 6-amino-7-aminomethyl-thiazolino-pyridones with aldehydes to construct amyloid affecting pyrimidine-fused thiazolino-2-pyridones
    Journal Name: Organic & Biomolecular Chemistry
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1039/d1ob01580j
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Protein network analysis links the NSL complex to Parkinson’s disease via mitochondrial and nuclear biology
    Journal Name: Molecular Omics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1039/d2mo00325b
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The East Asian Parkinson Disease Genomics Consortium
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00373-2
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Freezing of gait and levodopa
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00175-7
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Parkinson's disease-related pattern (PDRP) identified using resting-state functional MRI: Validation study
    Journal Name: Neuroimage: Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ynirp.2021.100026
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30449-x
    Citation Count: 321
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.